Pharmacogenetics: a practical role in predicting antiretroviral drug toxicity?

Journal of HIV therapy

Volumn 8, Issue 2, 2003, Pages 36-41

  Nolan, David ^a   Gaudieri, Silvana ^a   Mallal, Simon ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ABACAVIR; GLYCOPROTEIN P; HLA B ANTIGEN; HLA B*5701 ANTIGEN, HUMAN; HLA-B*5701 ANTIGEN, HUMAN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

BLOOD; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; PHARMACOGENETICS; PREDICTION AND FORECASTING; REVIEW;

DIDEOXYNUCLEOSIDES; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HLA-B ANTIGENS; HUMANS; P-GLYCOPROTEIN; PHARMACOGENETICS; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 1642568176     PISSN: 14620308     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)